InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Ryan Michael Charles, Dirigeant. Director active across 1 companies, notably Kiromic Biopharma, Inc.. Cumulatively, 2 disclosures have been published. The latest transaction was filed on 13 July 2021 — J. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
050,189 shares0
Common Stock
SEC:0001104659-21-098784·
050,189 shares0
Common Stock
SEC:0001104659-21-098784:0·
2 of 2 declarations
About Ryan Michael Charles
Ryan Michael Charles is an executive at Kiromic Biopharma, Inc. Although his specific functions are not mentioned, he plays an important role in the company's leadership. His expertise in the biopharmaceutical field and management experience are essential for the development and implementation of the company's strategies.
